United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-787_14060e9c-4605-5493-e063-6294a90ab6d3
- Product NDC
- 76420-787
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200301
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET in 1 BOTTLE (76420-787-01) · 76420-787-01
- 2 TABLET in 1 BOTTLE (76420-787-02) · 76420-787-02
- 500 TABLET in 1 BOTTLE (76420-787-05) · 76420-787-05
- 7 TABLET in 1 BOTTLE (76420-787-07) · 76420-787-07
- 100 TABLET in 1 BOTTLE (76420-787-10) · 76420-787-10
- 14 TABLET in 1 BOTTLE (76420-787-14) · 76420-787-14
- 20 TABLET in 1 BOTTLE (76420-787-20) · 76420-787-20
- 30 TABLET in 1 BOTTLE (76420-787-30) · 76420-787-30
- 60 TABLET in 1 BOTTLE (76420-787-60) · 76420-787-60
- 90 TABLET in 1 BOTTLE (76420-787-90) · 76420-787-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →